Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BioNTech Fills Coffers With Extra $325m Via Series B Financing

Executive Summary

Mainz-based BioNTech raises $325m in an upsized series B round to further advance its individualized immuno-oncology pipeline and manufacturing infrastructure.

Advertisement

Related Content

BioNTech Snaps Up Pancreatic Cancer Antibody, US Infrastructure
Sanofi Takes €80M BioNTech Stake & Extends 2015 Deal
Interview: BioNTech And Pfizer Explore mRNA Flu Vaccines In $120m+ Deal
BioNTech Raises $270M Series A Round To Pursue FIPCO Model

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC125510

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel